The pharmaceutical industry and Federal Drug Administration have let the American consumer down by manufacturing and quickly approving prescription drugs that cause more harm than good
Montgomery, Ala. (PRWEB) March 2, 2006
A Celebrex lawsuit has been set for trial on June 6, 2006, for a woman who suffered a stroke at age 53, caused by taking the pain relieving drug, Celebrex. The trial will take place in the Circuit Court of Barbour County in Alabama (Rosie Ware v. Pfizer, Inc, Monsanto Company, G.D. Searle, LLC, et al). It will most likely be the first Celebrex case to be tried in the country.
Rosie Ware took Celebrex (Celecoxib), a pharmaceutical treatment for joint pain associated with osteoarthritis and other pain-related conditions. She suffered a stroke in February 2005, and contends it was due to her use of Celebrex. As a result, Ms. Ware’s physical setback cost her substantial sums of money for medical, hospital and related care.
The lawsuit accuses Pfizer, Inc., Monsanto Company, Pharmacia, and G.D. Searle LLC (a subsidiary of Pharmacia) of failing to warn the medical, pharmaceutical, and scientific communities, and consumers -- including Ms. Ware -- and understating the potential risks and serious side effects associated with the use of Celebrex.
Attorneys representing Ms. Ware are Jere L. Beasley, Andy D. Birchfield, Paul Sizemore, and Navan Ward, Jr. with the law firm of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. in Montgomery, Alabama, and Shane Seaborn and Myron Penn with the law firm of Penn & Seaborn in Clayton, Alabama.
“The pharmaceutical industry and Federal Drug Administration have let the American consumer down by manufacturing and quickly approving prescription drugs that cause more harm than good,” Beasley said. “How many people need to be at risk or possibly die by taking drugs like Celebrex and Vioxx before industry standards improve?”
# # #